What is Laurus Labs Ltd (LAURUSLABS) share price today?

Laurus Labs Ltd (LAURUSLABS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/LAURUSLABS for the latest live price, technical analysis, and AI-powered insights.

How to analyse LAURUSLABS stock?

VestAI provides comprehensive LAURUSLABS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Laurus Labs Ltd in?

Laurus Labs Ltd (LAURUSLABS) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Laurus Labs Ltd

Q: What is Laurus Labs Ltd's Orion Score?

Laurus Labs Ltd has an Orion Score of 48/100 (Caution) — a fundamentals-based quality & risk score. Laurus Labs Ltd scores 48/100 (Caution) on the Orion Score — moderate business quality (62), moderate growth (58), weak balance-sheet safety (40) and rich valuation (2). A fundamentals-based quality & risk score, not a buy/sell recommendation.

LAURUSLABS

NSE· Healthcare

₹1,537.80

+30.40 (+2.02%)

Updated 12:32 pm IST

52W Low · ₹787.4052W High · ₹1,555.00

Near 52W High

Market Cap

₹78163.31L Cr

Volume

20.42L

Prev Close

₹1,507.40

ISIN

INE947Q01028

Orion Score

Fundamentals-based quality & risk · not a recommendation

48/100

Caution

Laurus Labs Ltd scores 48/100 (Caution) on the Orion Score — moderate business quality (62), moderate growth (58), weak balance-sheet safety (40) and rich valuation (2). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.8× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(5.80)Beneish M Clean(-2.64)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

67/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.46x — lean balance sheet

QUALITY

Average

ROCE 10.8% — decent returns

MOMENTUM

Neutral

RSI 69.7 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q3 FY2026

P/E Ratio: 92.57
ROCE: 10.79%
ROE (1Y): 17.74%
D/E Ratio: 0.46x
OPM: 20.22%
TTM EPS: ₹15.63
Dividend Yield: 17.00%
Qtrly Sales: ₹1,778.29 Cr
Qtrly Profit: ₹251.66 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q3 2026	₹1,778.29	₹251.66	20.2%	₹4.65
Q1 2026	₹1,569.57	₹163.02	16.9%	₹3.02
Q4 2025	₹1,674.2	₹233.67	18.5%	—
Q3 2025	₹1,415.05	₹92.3	12.7%	₹1.71
Q2 2025	₹1,223.7	₹19.84	5.8%	₹0.37

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹5,507.86	₹358.32	₹1,120.98	11.3%
FY 2024	₹5,001.8	₹160.55	₹792.7	7.9%
FY 2023	₹6,014.22	₹790.11	₹1,555.91	21.5%
FY 2022	₹4,888.54	₹827.52	₹1,411.1	24.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
LAURUSLABS ★	₹78,163 Cr	92.57	10.79%	17.74%	0.46x	20.22%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹9,335.57	₹8,387.03	₹7,660.4	₹6,968.04
Equity	₹4,472.56	₹4,110.95	₹4,037.53	₹3,351.19
Total Debt	₹2,763.73	₹2,577.4	₹2,015.09	₹1,776.66
Cash	₹99.54	₹138.94	₹45.67	₹75.58
Net Debt	₹2,593.54	₹2,368.11	₹1,926.3	₹1,656.45
Working Capital	₹792.6	₹722.69	₹1,029.42	₹663.6

Shareholding Pattern

Q1 FY2027

Promoter

32.16%

FII

23.76%

DII

19.44%

Public

24.64%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	32.16% ↑	23.76% ↓	19.44% ↑	24.64% ↓
Q3 FY2026	27.49% ↓	26.52% ↑	12.42% ↑	33.57% ↓
Q2 FY2026	27.6%	26.17% ↑	11.72% ↓	34.52% ↓
Q1 FY2026	27.6% ↓	25.7% ↑	11.94% ↑	34.78% ↓
Q4 FY2025	27.62%	25.51% ↓	11.78% ↓	35.09% ↑
Q3 FY2025	27.62% ↑	25.56% ↓	12.74% ↓	34.09% ↑
Q2 FY2025	27.18%	26.08% ↑	13.05% ↓	33.69% ↑
Q1 FY2025	27.18%	25.67%	13.56%	33.59%

Corporate Actions

Ex-Date	Action	Details
2026-05-08	DIVIDEND	Interim Dividend - Rs 1.20 Per Share

Smart Money Holdings

Q4 FY2025

Investor	Shares Held	Portfolio %	Change
capital-group	—	—	—
akash-bhanshali	40,00,000	7.00%	—
akash-bhanshali	71,51,700	1.30%	—

Funds Holding This Stock

150 mutual fund schemes

Tata Nifty MidSmall Healthcare Index Fund Direct GrowthTATA

8.82%

₹15 Cr

Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct GrowthMOTILAL_OSWAL

8.82%

₹3 Cr

ICICI Prudential Nifty Pharma Index Fund Direct GrowthICICI_PRUDENTIAL

5.93%

₹8 Cr

Baroda BNP Paribas Health and Wellness Fund Direct GrowthBARODABNPPARIBASMUTUALFUND_MF

5.76%

₹31 Cr

Tata Nifty200 Alpha 30 Index Fund Direct GrowthTATA

5.15%

₹10 Cr

DSP Nifty Healthcare Index Fund Direct GrowthDSP

5.08%

₹1 Cr

ITI Pharma and Healthcare Fund Direct GrowthITI

5.06%

₹12 Cr

Kotak Active Momentum Fund Direct GrowthKOTAK_MAHINDRA

4.50%

₹67 Cr

WhiteOak Capital Pharma and Healthcare Fund Direct GrowthWHITEOAK_CAPITAL

4.43%

₹29 Cr

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

4.35%

₹135 Cr

Analyse LAURUSLABS with Orion AI

Ask: "Is Laurus Labs Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Laurus Labs Ltd (LAURUSLABS) Stock

Laurus Labs Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE947Q01028. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.